Delivery Order SPE2DB22D1202-SPE2DB25FVHU5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,257.48 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of August 11, 2025. This is a firm fixed-price, non-set-aside contract for delivery to AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting the federal government's medical supply needs through AmerisourceBergen's established vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,341.20 to AmerisourceBergen Drug Corp for Rabavert Rabies Vaccine with diluents, with performance in Conshohocken, Pennsylvania. This firm fixed-price delivery order, awarded on August 15, 2025, represents a non-competitive procurement and is scheduled for completion by August 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical...
- The Defense Logistics Agency awarded a $2,095.80 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The vaccine will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $2,816.02 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply requirements. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and carries no set-aside...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $40,441.62 for Rabavert rabies vaccine with diluents under a firm fixed-price contract. This non-set-aside award, issued on July 29, 2025, represents a child order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The vaccine will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency awarded a $29,341.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of July 30, 2025. This competitively awarded contract, issued without set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The vaccine will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,353.33 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This firm fixed-price delivery order, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, was competitively awarded without any set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,303.22 to AmerisourceBergen Drug Corp for the supply of Rabavert rabies vaccine with diluents. The contract, issued on July 20, 2025, with an ultimate completion date of July 21, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania, supporting the agency's medical supply chain...
- The Defense Logistics Agency awarded a delivery order valued at $1,702.41 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This firm fixed price delivery order, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The contract carries no set-aside designation and was competitively awarded. Performance will take place at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $26,596.25 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This firm fixed-price contract, effective July 25, 2025, with ultimate completion by July 28, 2025, represents a small-value pharmaceutical procurement from the prime contractor's place of business in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVHU5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,149.60 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This contract was competitively awarded without set-aside designation and carries an ultimate completion date of August 20, 2025. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under a firm fixed price structure, providing the federal government with predetermined pricing for this critical pharmaceutical commodity. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare systems worldwide. The company's extensive federal contracting history demonstrates its role as a major pharmaceutical distributor serving defense medical procurement needs, including support for the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.1k | 8/19/25 |